Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 12 | 2018 | 63 | 4.110 |
Why?
|
| Burkholderia pseudomallei | 7 | 2021 | 40 | 3.370 |
Why?
|
| Gene Expression Regulation, Bacterial | 10 | 2021 | 171 | 2.440 |
Why?
|
| Bacterial Proteins | 11 | 2021 | 595 | 2.360 |
Why?
|
| Genes, Bacterial | 7 | 2021 | 91 | 2.110 |
Why?
|
| Fatty Acids | 6 | 2014 | 134 | 1.780 |
Why?
|
| Oculomotor Nerve Diseases | 2 | 2025 | 3 | 1.630 |
Why?
|
| Burkholderia | 5 | 2011 | 17 | 1.600 |
Why?
|
| Intraocular Pressure | 2 | 2024 | 132 | 1.440 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 704 | 1.330 |
Why?
|
| Operon | 5 | 2014 | 43 | 1.260 |
Why?
|
| Melioidosis | 3 | 2021 | 27 | 1.200 |
Why?
|
| Pseudomonas Infections | 4 | 2018 | 23 | 1.090 |
Why?
|
| Biofilms | 3 | 2018 | 184 | 1.080 |
Why?
|
| DNA, Bacterial | 7 | 2018 | 206 | 1.050 |
Why?
|
| Virulence Factors | 4 | 2021 | 125 | 1.010 |
Why?
|
| Pancreatic Cyst | 1 | 2026 | 7 | 0.960 |
Why?
|
| Rhabdoid Tumor | 1 | 2025 | 5 | 0.910 |
Why?
|
| Teratoma | 1 | 2025 | 10 | 0.900 |
Why?
|
| Genetic Engineering | 3 | 2011 | 37 | 0.900 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2026 | 67 | 0.890 |
Why?
|
| Optic Nerve Diseases | 1 | 2024 | 30 | 0.840 |
Why?
|
| Transcription Factors | 3 | 2018 | 735 | 0.810 |
Why?
|
| Pancreatic Neoplasms | 1 | 2026 | 218 | 0.770 |
Why?
|
| Computational Biology | 3 | 2021 | 327 | 0.740 |
Why?
|
| Myofibroma | 1 | 2021 | 1 | 0.730 |
Why?
|
| Genetic Vectors | 3 | 2018 | 165 | 0.730 |
Why?
|
| Plasmids | 4 | 2017 | 244 | 0.710 |
Why?
|
| Aspartate-Semialdehyde Dehydrogenase | 4 | 2018 | 4 | 0.710 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2021 | 1 | 0.710 |
Why?
|
| Adie Syndrome | 1 | 2021 | 1 | 0.700 |
Why?
|
| Exophthalmos | 1 | 2021 | 1 | 0.700 |
Why?
|
| Ophthalmic Artery | 1 | 2021 | 4 | 0.700 |
Why?
|
| Mice, Inbred BALB C | 6 | 2021 | 694 | 0.700 |
Why?
|
| Mutation | 8 | 2023 | 1177 | 0.700 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 23 | 0.700 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 53 | 0.690 |
Why?
|
| Eyebrows | 1 | 2021 | 2 | 0.690 |
Why?
|
| Repressor Proteins | 2 | 2021 | 273 | 0.690 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 70 | 0.680 |
Why?
|
| Glycine | 2 | 2011 | 47 | 0.640 |
Why?
|
| Melanoma | 1 | 2021 | 110 | 0.620 |
Why?
|
| Sequence Analysis, DNA | 4 | 2015 | 515 | 0.600 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 178 | 0.590 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 1542 | 0.560 |
Why?
|
| Choline | 3 | 2014 | 61 | 0.550 |
Why?
|
| Gene Library | 1 | 2017 | 62 | 0.540 |
Why?
|
| Virulence | 5 | 2021 | 246 | 0.520 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 1092 | 0.520 |
Why?
|
| Diabetic Retinopathy | 3 | 2022 | 78 | 0.500 |
Why?
|
| Phosphatidylcholines | 2 | 2014 | 35 | 0.500 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2009 | 90 | 0.490 |
Why?
|
| Base Sequence | 8 | 2011 | 983 | 0.480 |
Why?
|
| Humans | 20 | 2026 | 43102 | 0.470 |
Why?
|
| Prokaryotic Cells | 1 | 2015 | 9 | 0.460 |
Why?
|
| Anti-Bacterial Agents | 2 | 2009 | 432 | 0.460 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 561 | 0.450 |
Why?
|
| Mice | 8 | 2023 | 6644 | 0.450 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 74 | 0.450 |
Why?
|
| Animals | 12 | 2023 | 16992 | 0.440 |
Why?
|
| Coenzyme A Ligases | 2 | 2013 | 5 | 0.440 |
Why?
|
| Glycerol | 1 | 2014 | 34 | 0.430 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 95 | 0.410 |
Why?
|
| Cystic Fibrosis | 2 | 2014 | 28 | 0.370 |
Why?
|
| Molecular Biology | 2 | 2010 | 47 | 0.370 |
Why?
|
| Selection, Genetic | 2 | 2009 | 75 | 0.370 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 539 | 0.370 |
Why?
|
| Chromosomes, Bacterial | 4 | 2017 | 21 | 0.370 |
Why?
|
| DNA | 1 | 2015 | 592 | 0.360 |
Why?
|
| Vaccines, Attenuated | 1 | 2011 | 75 | 0.350 |
Why?
|
| Sequence Deletion | 1 | 2011 | 93 | 0.350 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 40 | 0.340 |
Why?
|
| Ultrasonography | 2 | 2021 | 135 | 0.330 |
Why?
|
| Staining and Labeling | 1 | 2010 | 107 | 0.320 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 129 | 0.320 |
Why?
|
| Fluorescence | 1 | 2010 | 118 | 0.320 |
Why?
|
| Genes, Essential | 1 | 2009 | 5 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 587 | 0.310 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 39 | 0.310 |
Why?
|
| Tellurium | 1 | 2009 | 5 | 0.300 |
Why?
|
| Sigma Factor | 1 | 2009 | 19 | 0.300 |
Why?
|
| Lung | 2 | 2014 | 492 | 0.300 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 37 | 0.280 |
Why?
|
| 4-Butyrolactone | 2 | 2009 | 13 | 0.270 |
Why?
|
| Bacteriophage T7 | 1 | 2007 | 1 | 0.270 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1596 | 0.270 |
Why?
|
| Cloning, Molecular | 4 | 2011 | 314 | 0.260 |
Why?
|
| Drosophila melanogaster | 2 | 2018 | 193 | 0.250 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 1180 | 0.250 |
Why?
|
| Food | 1 | 2007 | 103 | 0.250 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 209 | 0.250 |
Why?
|
| Male | 7 | 2023 | 23409 | 0.230 |
Why?
|
| Craniotomy | 1 | 2025 | 5 | 0.230 |
Why?
|
| Fatal Outcome | 1 | 2025 | 48 | 0.230 |
Why?
|
| Cost-Benefit Analysis | 1 | 2026 | 179 | 0.220 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2024 | 3 | 0.220 |
Why?
|
| Low Tension Glaucoma | 1 | 2024 | 2 | 0.210 |
Why?
|
| Tonometry, Ocular | 1 | 2024 | 27 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 245 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 652 | 0.200 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2002 | 23 | 0.190 |
Why?
|
| Glaucoma | 1 | 2024 | 100 | 0.190 |
Why?
|
| Myopia, Degenerative | 1 | 2022 | 1 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 267 | 0.180 |
Why?
|
| Macular Degeneration | 1 | 2022 | 31 | 0.180 |
Why?
|
| Oculomotor Nerve | 1 | 2021 | 4 | 0.180 |
Why?
|
| Skull Base | 1 | 2021 | 5 | 0.180 |
Why?
|
| Retinal Diseases | 1 | 2022 | 20 | 0.180 |
Why?
|
| Myopia | 1 | 2022 | 27 | 0.180 |
Why?
|
| Structure-Activity Relationship | 1 | 2023 | 506 | 0.180 |
Why?
|
| Bacteria | 2 | 2015 | 293 | 0.180 |
Why?
|
| Cerebral Angiography | 1 | 2021 | 7 | 0.180 |
Why?
|
| Carotid Artery, Internal | 1 | 2021 | 8 | 0.180 |
Why?
|
| Ophthalmoscopy | 1 | 2021 | 12 | 0.180 |
Why?
|
| Regulon | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cell Line | 2 | 2018 | 1410 | 0.180 |
Why?
|
| Eye Neoplasms | 1 | 2021 | 2 | 0.170 |
Why?
|
| Radiation Oncology | 1 | 2021 | 2 | 0.170 |
Why?
|
| SOXE Transcription Factors | 1 | 2021 | 3 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2023 | 220 | 0.170 |
Why?
|
| Vacuoles | 1 | 2021 | 22 | 0.170 |
Why?
|
| Eye Injuries | 1 | 2021 | 6 | 0.170 |
Why?
|
| Aftercare | 1 | 2021 | 22 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 133 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2026 | 449 | 0.170 |
Why?
|
| Recreation | 1 | 2021 | 43 | 0.170 |
Why?
|
| Arteries | 1 | 2021 | 81 | 0.170 |
Why?
|
| Prognosis | 1 | 2023 | 861 | 0.170 |
Why?
|
| Cytoplasm | 1 | 2021 | 154 | 0.170 |
Why?
|
| Biopsy | 1 | 2021 | 177 | 0.160 |
Why?
|
| Eye | 1 | 2021 | 77 | 0.160 |
Why?
|
| Child, Preschool | 1 | 2025 | 1546 | 0.160 |
Why?
|
| Adult | 5 | 2022 | 13872 | 0.160 |
Why?
|
| Transformation, Bacterial | 2 | 2011 | 12 | 0.160 |
Why?
|
| DNA Transposable Elements | 2 | 2010 | 55 | 0.160 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 164 | 0.150 |
Why?
|
| Phenazines | 1 | 2018 | 6 | 0.150 |
Why?
|
| Genetic Complementation Test | 2 | 2009 | 56 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2021 | 403 | 0.140 |
Why?
|
| Genetic Techniques | 1 | 2018 | 14 | 0.140 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2018 | 57 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 296 | 0.140 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 100 | 0.140 |
Why?
|
| Vietnam | 3 | 2022 | 62 | 0.140 |
Why?
|
| Transformation, Genetic | 1 | 2017 | 20 | 0.140 |
Why?
|
| Sequence Alignment | 2 | 2015 | 272 | 0.140 |
Why?
|
| Clone Cells | 1 | 2017 | 50 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 63 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 495 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 310 | 0.130 |
Why?
|
| Escherichia coli | 2 | 2010 | 460 | 0.130 |
Why?
|
| Species Specificity | 1 | 2017 | 286 | 0.130 |
Why?
|
| DNA Repair | 1 | 2018 | 198 | 0.130 |
Why?
|
| Binding Sites | 1 | 2018 | 671 | 0.130 |
Why?
|
| Drosophila | 1 | 2017 | 152 | 0.130 |
Why?
|
| Alleles | 1 | 2017 | 352 | 0.120 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1604 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2014 | 2157 | 0.120 |
Why?
|
| Rhinovirus | 1 | 2015 | 2 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2015 | 45 | 0.110 |
Why?
|
| Coronavirus | 1 | 2015 | 9 | 0.110 |
Why?
|
| Cell Separation | 1 | 2015 | 94 | 0.110 |
Why?
|
| Influenza A virus | 1 | 2015 | 31 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2018 | 561 | 0.110 |
Why?
|
| DNA, Complementary | 1 | 2015 | 196 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 183 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 207 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1271 | 0.110 |
Why?
|
| Mutagenesis | 1 | 2014 | 91 | 0.110 |
Why?
|
| Female | 3 | 2025 | 24698 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2853 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1081 | 0.100 |
Why?
|
| Genome | 1 | 2015 | 149 | 0.100 |
Why?
|
| Genome, Bacterial | 1 | 2015 | 139 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 174 | 0.100 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2676 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 191 | 0.100 |
Why?
|
| Terpenes | 1 | 2013 | 30 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 307 | 0.100 |
Why?
|
| Brain | 1 | 2021 | 1472 | 0.100 |
Why?
|
| Algorithms | 1 | 2015 | 509 | 0.090 |
Why?
|
| Inhalation | 1 | 2011 | 8 | 0.090 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 7 | 0.090 |
Why?
|
| Microdissection | 1 | 2011 | 13 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 53 | 0.090 |
Why?
|
| Acute Disease | 1 | 2011 | 155 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 64 | 0.090 |
Why?
|
| Bacteriophages | 1 | 2011 | 44 | 0.080 |
Why?
|
| Phylogeny | 1 | 2015 | 769 | 0.080 |
Why?
|
| Genetics, Microbial | 1 | 2010 | 5 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2010 | 97 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 68 | 0.080 |
Why?
|
| Phenotype | 1 | 2013 | 780 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2010 | 219 | 0.080 |
Why?
|
| Acetyltransferases | 1 | 2009 | 27 | 0.080 |
Why?
|
| Oleic Acid | 1 | 2009 | 15 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2009 | 42 | 0.080 |
Why?
|
| Artificial Gene Fusion | 1 | 2009 | 5 | 0.080 |
Why?
|
| Quorum Sensing | 1 | 2009 | 16 | 0.080 |
Why?
|
| Osmotic Pressure | 1 | 2009 | 22 | 0.070 |
Why?
|
| Kinetics | 1 | 2010 | 695 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2009 | 148 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 186 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2009 | 168 | 0.070 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2008 | 1 | 0.070 |
Why?
|
| Time Factors | 1 | 2013 | 1857 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 423 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2008 | 150 | 0.070 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 133 | 0.070 |
Why?
|
| RNA, Bacterial | 1 | 2007 | 40 | 0.070 |
Why?
|
| Macrophages | 1 | 2011 | 529 | 0.060 |
Why?
|
| DNA Primers | 1 | 2007 | 294 | 0.060 |
Why?
|
| Glucose | 1 | 2008 | 244 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2023 | 2544 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 518 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 526 | 0.060 |
Why?
|
| Protein Binding | 1 | 2009 | 1082 | 0.060 |
Why?
|
| Castration | 1 | 2023 | 34 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 29 | 0.050 |
Why?
|
| Adolescent | 2 | 2022 | 6081 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 12 | 0.050 |
Why?
|
| Griseofulvin | 1 | 2023 | 4 | 0.050 |
Why?
|
| Acylation | 1 | 2002 | 11 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 8 | 0.050 |
Why?
|
| Centrosome | 1 | 2023 | 30 | 0.050 |
Why?
|
| State Medicine | 1 | 2022 | 8 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 19 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2022 | 51 | 0.050 |
Why?
|
| Prostate | 1 | 2023 | 155 | 0.050 |
Why?
|
| Photography | 1 | 2022 | 50 | 0.050 |
Why?
|
| Atrophy | 1 | 2022 | 51 | 0.050 |
Why?
|
| Fundus Oculi | 1 | 2021 | 7 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2022 | 111 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 611 | 0.040 |
Why?
|
| Software | 1 | 2021 | 236 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2022 | 574 | 0.040 |
Why?
|
| Retina | 1 | 2021 | 289 | 0.040 |
Why?
|
| Mass Screening | 1 | 2022 | 541 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1997 | 26 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 1612 | 0.030 |
Why?
|
| Middle Aged | 2 | 2022 | 12222 | 0.030 |
Why?
|
| Child | 1 | 2022 | 3443 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3156 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 5080 | 0.020 |
Why?
|
| Aged | 1 | 2022 | 8214 | 0.020 |
Why?
|